Skip to content
All tests

Your test, explained

5 min read

Prolactin Serum Blood Test: Pituitary Function & Fertility Screen

A highly precise quantitative measurement of serum prolactin. It is the frontline diagnostic tool utilized to detect prolactin-secreting pituitary adenomas, evaluate hypogonadism, and diagnose the root causes of amenorrhea and galactorrhea.

At a glance

Start with the details.

A price isn’t listed yet. Explore the guide below.

Sample
Blood (Serum)
Typical turnaround
1 - 2 days
Before your appointment

Your options, side by side

Compare retailer prices.

Find a listing that fits your needs. Review the details, then order with the retailer.

0 listings

No retailer listings yet.

Read the test guide or explore other tests in the directory.

Explore tests

Prices shown are listed test prices, not checkout totals. Expand a listing for supplied fees and its observation date. Check included measurements, collection requirements, and the performing lab before ordering.

Understand before you decide

The test, explained.

Overview

Prolactin is frequently dismissed as simply the 'milk-producing hormone' relevant only to nursing mothers. In advanced clinical endocrinology, it is recognized as a profound physiological stress biomarker and a primary regulator of the human reproductive axis.

As a senior clinical biologist who has dedicated extensive research to pituitary diagnostics, I want to reassure you: while hearing the word 'tumor' associated with this test can be frightening, prolactinomas are typically benign, highly treatable, and often managed entirely with medication rather than surgery. This blood test measures the exact concentration of prolactin secreted by your anterior pituitary gland. Because prolactin has an inverse relationship with dopamine (your brain's 'reward' chemical inhibits prolactin), measuring its levels gives us a direct window into your neurological and endocrine health. It is the gold-standard first step for investigating unexplained infertility, suppressed sex drive, and menstrual cessation.

About this test

Advanced Clinical Diagnostic Utility of Prolactin

To extract genuine clinical utility from this endocrine panel, one must understand how prolactin interacts with the broader reproductive system and how it responds to physiological stress.

1. The Pituitary-Gonadal Suppression (The Fertility Block)
  • The GnRH Inhibitor: In both men and women, abnormally high prolactin (hyperprolactinemia) acts as a systemic reproductive brake. It suppresses the release of Gonadotropin-Releasing Hormone (GnRH) from the hypothalamus. Without GnRH, your body will not produce Luteinizing Hormone (LH) or Follicle-Stimulating Hormone (FSH). In women, this halts ovulation and stops menstrual cycles. In men, it halts testosterone production, leading to severe erectile dysfunction and testicular atrophy. Correcting prolactin often instantly restores fertility.

2. The Prolactinoma vs. The 'Stalk Effect'
  • Differentiating Tumors: A prolactinoma is a benign tumor of the pituitary gland that actively secretes prolactin, often driving serum levels above 200 ng/mL. However, any large mass in the pituitary region can compress the pituitary stalk. Because dopamine travels down this stalk to tell the pituitary to stop making prolactin, a compressed stalk blocks the dopamine, causing prolactin to rise (usually between 50-150 ng/mL). This 'Stalk Effect' is why precision measurement and expert interpretation are crucial before ordering an MRI.

3. The Macroprolactin Conundrum
  • Biologically Inactive Hormone: Sometimes, a patient returns a frighteningly high prolactin level, yet has absolutely no symptoms. This is often due to 'Macroprolactinemia.' In this benign condition, prolactin molecules bind to IgG antibodies, creating a massive molecular complex that cannot exit the bloodstream to activate cellular receptors. It triggers the lab assay but does nothing in the body. Advanced reflex testing using Polyethylene Glycol (PEG) precipitation is required to filter this out and reveal your true, bioactive (monomeric) prolactin level.

When to discuss this test

You should prioritize this targeted endocrine evaluation when:

  • Women: You are experiencing unexplained milk production (galactorrhea) despite not being pregnant or nursing, have sudden cessation of your menstrual cycles (amenorrhea), or are struggling with unexplained infertility.
  • Men: You suffer from sudden, profound erectile dysfunction, total loss of morning erections, enlarged breast tissue (gynecomastia), or peripheral vision loss (bitemporal hemianopsia) combined with chronic headaches.
  • Medication Monitoring: You are taking dopamine-blocking medications (such as certain psychiatric drugs) and need to monitor for medication-induced hyperprolactinemia.
  • Prolactinoma Management: You are currently taking a dopamine agonist (like Cabergoline or Bromocriptine) to shrink a known pituitary tumor and need to monitor therapeutic efficacy.

Who may benefit

This test is an absolute necessity for reproductive endocrinologists evaluating anovulatory infertility, neuro-endocrinologists tracking the shrinkage of pituitary adenomas, urologists differentiating the root causes of male hypogonadism, and primary care physicians investigating chronic, unexplained headaches combined with hormonal dysfunction.

How this test is used

  • Prolactinoma (Pituitary Micro/Macroadenoma)
  • Hypogonadotropic Hypogonadism (Male and Female)
  • Macroprolactinemia
  • Pharmacological (Drug-Induced) Hyperprolactinemia

Before your appointment

Plan your visit.

Fasting
Follow retailer guidance
Collection timing
Morning collection preferred

How to prepare

  • Strict Timing (3-4 Hours Post-Waking): Prolactin follows a sleep-dependent rhythm. It surges during sleep and peaks right as you wake up. Drawing blood immediately upon waking will yield a falsely elevated result. You must wait 3 to 4 hours after waking before having your blood drawn.
  • Strict Fasting (8 Hours): While some basic lab manuals suggest fasting is not required, this is a clinical error for optimal baseline accuracy. High-protein meals stimulate the release of certain amino acids that can transiently spike prolactin levels. An 8-hour water-only fast ensures we are measuring your true pituitary baseline, not a dietary artifact.
  • Avoid Physical and Sexual Stress (24 Hours): Prolactin is an acute stress hormone. Intense cardiovascular exercise, sexual intercourse, and specifically any stimulation of the chest/nipple area within 24 hours of the test will cause a massive, artificial spike in serum prolactin. Abstain from these activities prior to your draw.
  • Disclose Medications: You must explicitly inform your physician of your medications. Antipsychotics, SSRI antidepressants, anti-nausea drugs (like Metoclopramide), and high-dose estrogens drastically artificially inflate prolactin levels.

Important considerations

The 'Hook Effect' in Massive Tumors: In rare cases involving massive macroprolactinomas (tumors >1 cm), the amount of prolactin in the blood is so extraordinarily high that it overwhelms the laboratory's immunoassay antibodies, resulting in a falsely low or 'normal' reading on the final report. If a patient has a massive pituitary tumor on an MRI but normal prolactin lab results, the lab must be instructed to dilute the serum sample (1:100) to bypass this 'Hook Effect' and reveal the true, sky-high level.

Follow the instructions from your retailer and clinician. Information on this page is educational and does not replace individual medical advice.

See what to expect

Sample reports & resources.

Published examples and supporting files for this test.

No sample files are published for this test yet.

Looking for your own results? Open your reports dashboard

For a closer look

Sources & further reading.

Further reading

Recent Clinical Breakthroughs (2025-2026):

  • Routine Macroprolactin Screening Mandate: A 2025 consensus published in The Journal of Clinical Endocrinology & Metabolism successfully established routine Polyethylene Glycol (PEG) precipitation for all asymptomatic patients presenting with mild hyperprolactinemia. This mandatory reflex testing has successfully reduced unnecessary pituitary MRI scans by over 35%, saving patients from immense financial burden and anxiety caused by biologically inactive macroprolactin.
  • Prolactin and Metabolic Syndrome: Breakthrough 2025 research in Endocrine Reviews has shifted the paradigm of prolactin beyond reproduction. Mild, physiological elevations within the high-normal range have been proven to promote pancreatic beta-cell survival and improve insulin sensitivity. Conversely, pathologically low prolactin is now recognized as an independent risk factor for the development of Type 2 Diabetes and metabolic syndrome.
  • Cabergoline Tapering Guidelines: 2026 neuro-endocrinology updates have refined the withdrawal protocol for prolactinomas. Patients who have maintained normal prolactin levels and invisible tumor volume on MRI for 24 consecutive months on low-dose Cabergoline are now formally recommended for a supervised medication taper, with a 65% long-term remission rate.

Sources